UDR不动产信托 UDR 深 沪
等待开盘 11-06 09:30:00 美东时间
34.431
+0.161
+0.47%
华盛通- 最 高34.53
- 今 开34.32
- 成交量 197.17万股
- 最 低 34.01
- 昨 收 34.27
- 总市值 113.97亿
- 52周最高 45.18
- 市盈率 静 134.13
- 换手率 0.60%
- 52周最低 32.94
- 委 比 -49.92%
- 总股本 3.31亿
- 历史最高 54.5075
- 量 比 0.51
- 振 幅 1.52%
- 历史最低 3.395
- 每 手 1
- 风险率 2.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
Piper Sandler Maintains Neutral on UDR, Lowers Price Target to $39
Piper Sandler analyst Alexander Goldfarb maintains UDR (NYSE:UDR) with a Neutral and lowers the price target from $43 to $39.
11-03 21:10
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's
10-30 00:47
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Mid-America Apartment's Earnings: A Preview
Mid-America Apartment (NYSE:MAA) is preparing to release its quarterly earnings...
10-29 02:02
Earnings Preview: Essex Property Trust
Essex Property Trust (NYSE:ESS) is gearing up to announce its quarterly earning...
10-29 01:03
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
Forecasting The Future: 11 Analyst Projections For UDR
Throughout the last three months, 11 analysts have evaluated UDR (NYSE:UDR), of...
10-13 21:01
公司简介
公司名称
|
UDR不动产信托
|
行业分类
|
--
|
业务描述
|
标准普尔500强企业UDR公司（NYSE：UDR）是一家领先的多户房地产投资信托公司，在成功管理，购买，销售，开发和重新开发有吸引力的房地产物业方面，表现出卓越而可靠的业绩， 有针对性的美国市场，截至2017年9月30日，UDR拥有或拥有50,127户公寓（包括2,935个房屋），或者实际上是开发商资本项目，超过45年来，UDR为股东， 为居民提供最好的服务标准，为员工提供最优质的服务。
|
美股大行评级 | 最高255美元！9家大行集体上调Palantir目标价；Axsome、Exact、Fabrinet、ZoomInfo、爱德士、MongoDB、安森美半导体等也获多家大行上调目标价
今日重点评级关注：瑞银：维持Syndax Pharmaceuticals"买入"评级，目标价从35美元升至38美元；HC Wainwright & Co.：维持Benitec Biopharma"买入"评级，目标价从28美元升至35美元
11-05 10:35
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
Piper Sandler Maintains Neutral on UDR, Lowers Price Target to $39
Piper Sandler analyst Alexander Goldfarb maintains UDR (NYSE:UDR) with a Neutral and lowers the price target from $43 to $39.
11-03 21:10
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelled the S&P 500 above the 6,900 mark and lifted the Nasdaq 100 to 26,100 points, both breaking new records, as investors brace for the Federal Reserve's
10-30 00:47
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Mid-America Apartment's Earnings: A Preview
Mid-America Apartment (NYSE:MAA) is preparing to release its quarterly earnings...
10-29 02:02
Earnings Preview: Essex Property Trust
Essex Property Trust (NYSE:ESS) is gearing up to announce its quarterly earning...
10-29 01:03
美股大行评级 | 潜在最高涨幅37.45%，甲骨文获多家机构上调目标价；瑞穗上调美光科技目标价升至240美元
今日重点评级关注：韦德布什：维持Artiva Biotherapeutics"跑赢大市"评级，目标价从18美元升至23美元；巴克莱：维持Cellectis"超配"评级，目标价从4美元升至8美元
10-20 10:03
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
Forecasting The Future: 11 Analyst Projections For UDR
Throughout the last three months, 11 analysts have evaluated UDR (NYSE:UDR), of...
10-13 21:01
派息除权日
|
每股总股息
| 派息日期 |
2025-10-09
|
0.43
|
2025-10-31
|
2025-07-10
|
0.43
|
2025-07-31
|
2025-04-10
|
0.43
|
2025-04-30
|
2025-01-10
|
0.43
|
2025-01-31
|
2024-10-10
|
0.43
|
2024-10-31
|
2024-07-10
|
0.43
|
2024-07-31
|
2024-04-09
|
0.43
|
2024-04-30
|
2024-01-09
|
0.42
|
2024-01-31
|
2023-10-06
|
0.42
|
2023-10-31
|
2023-07-07
|
0.42
|
2023-07-31
|
2023-04-06
|
0.42
|
2023-05-01
|
2023-01-06
|
0.38
|
2023-01-31
|
2022-10-07
|
0.38
|
2022-10-31
|
2022-07-08
|
0.38
|
2022-08-01
|
2022-04-08
|
0.38
|
2022-05-02
|
2022-01-07
|
0.36
|
2022-01-31
|
2021-10-07
|
0.36
|
2021-11-01
|
2021-07-09
|
0.36
|
2021-08-02
|
2021-04-08
|
0.36
|
2021-04-30
|
2021-01-08
|
0.36
|
2021-02-01
|
2020-10-08
|
0.36
|
2020-11-02
|
2020-07-09
|
0.36
|
2020-07-31
|
2020-04-08
|
0.36
|
2020-04-30
|
2020-01-09
|
0.34
|
2020-01-31
|
2019-10-09
|
0.34
|
2019-10-31
|
2019-07-09
|
0.34
|
2019-07-31
|
2019-04-08
|
0.34
|
2019-04-30
|
2019-01-09
|
0.32
|
2019-01-31
|
2018-10-09
|
0.32
|
2018-10-31
|
2018-07-09
|
0.32
|
2018-07-31
|
2018-04-06
|
0.32
|
2018-04-30
|
2018-01-09
|
0.31
|
2018-01-31
|
2017-10-06
|
0.31
|
2017-10-31
|
2017-07-06
|
0.31
|
2017-07-31
|
2017-04-06
|
0.31
|
2017-05-01
|
2017-01-06
|
0.29
|
2017-01-31
|
2016-10-06
|
0.29
|
2016-10-31
|
2016-07-07
|
0.29
|
2016-08-01
|
2016-04-07
|
0.29
|
2016-05-02
|
2016-01-07
|
0.28
|
2016-02-01
|
2015-10-07
|
0.28
|
2015-11-02
|
2015-07-08
|
0.28
|
2015-07-31
|
2015-04-14
|
0.28
|
2015-04-30
|
2015-01-08
|
0.26
|
2015-02-02
|
2014-10-08
|
0.26
|
2014-10-31
|
2014-07-08
|
0.26
|
2014-07-31
|
2014-04-07
|
0.26
|
2014-04-30
|
2014-01-08
|
0.23
|
2014-01-31
|
2013-10-08
|
0.23
|
2013-10-31
|
2013-07-08
|
0.23
|
2013-07-31
|
2013-04-05
|
0.23
|
2013-04-30
|
2013-01-08
|
0.22
|
2013-01-31
|
2012-10-05
|
0.22
|
2012-10-31
|
2012-07-06
|
0.22
|
2012-07-31
|
2012-04-04
|
0.22
|
2012-04-30
|
2012-01-09
|
0.22
|
2012-01-31
|
2011-10-12
|
0.20
|
2011-10-31
|
2011-07-07
|
0.20
|
2011-08-01
|
2011-04-07
|
0.19
|
2011-05-02
|
2011-01-12
|
0.19
|
2011-01-31
|
2010-10-13
|
0.19
|
2010-11-01
|
2010-07-08
|
0.18
|
2010-08-02
|
2010-04-08
|
0.18
|
2010-04-30
|
2010-01-13
|
0.18
|
2010-02-01
|
2009-10-14
|
0.18
|
2009-11-02
|
2009-07-08
|
0.18
|
2009-07-31
|
2009-04-07
|
0.31
|
2009-04-30
|
2008-12-05
|
1.30
|
2009-01-29
|
2008-10-15
|
0.33
|
2008-10-31
|
2008-07-09
|
0.33
|
2008-07-31
|
2008-04-09
|
0.33
|
2008-04-30
|
2008-01-09
|
0.33
|
2008-01-31
|
2007-10-10
|
0.33
|
2007-10-31
|
2007-07-11
|
0.33
|
2007-07-31
|
2007-04-11
|
0.33
|
2007-04-30
|
2007-01-10
|
0.31
|
2007-01-31
|
2006-10-11
|
0.31
|
2006-10-31
|
2006-07-12
|
0.31
|
2006-07-31
|
2006-04-11
|
0.31
|
2006-05-01
|
2006-01-11
|
0.30
|
2006-01-31
|
2005-10-12
|
0.30
|
2005-10-31
|
2005-07-13
|
0.30
|
2005-08-01
|
2005-04-13
|
0.30
|
2005-05-02
|
2005-01-12
|
0.29
|
2005-01-31
|
2004-10-13
|
0.29
|
2004-11-01
|
2004-07-14
|
0.29
|
2004-08-02
|
2004-04-14
|
0.29
|
2004-04-30
|
2004-01-14
|
0.28
|
2004-02-02
|
2003-10-15
|
0.28
|
2003-10-31
|
2003-07-16
|
0.28
|
2003-07-31
|
2003-04-09
|
0.28
|
2003-04-30
|
2003-01-15
|
0.28
|
2003-01-31
|
2002-10-09
|
0.28
|
2002-10-31
|
2002-07-10
|
0.28
|
2002-07-31
|
2002-04-10
|
0.28
|
2002-04-30
|
2002-01-11
|
0.27
|
2002-01-31
|
2001-10-10
|
0.27
|
2001-10-31
|
2001-07-11
|
0.27
|
2001-07-31
|
2001-04-10
|
0.27
|
2001-04-30
|
2001-01-10
|
0.27
|
2001-01-30
|
2000-10-11
|
0.27
|
2000-10-31
|
2000-07-12
|
0.27
|
2000-07-31
|
2000-04-12
|
0.27
|
2000-04-28
|
2000-01-12
|
0.26
|
2000-01-31
|
1999-10-13
|
0.26
|
1999-11-01
|
1999-07-14
|
0.26
|
1999-07-30
|
1999-04-14
|
0.26
|
1999-04-30
|
1999-01-13
|
0.26
|
1999-01-29
|
1998-10-14
|
0.26
|
1998-10-30
|
1998-07-15
|
0.26
|
1998-07-31
|
1998-04-07
|
0.26
|
1998-04-30
|
1998-01-14
|
0.25
|
1998-01-30
|
1997-10-15
|
0.25
|
1997-10-31
|
1997-07-09
|
0.25
|
1997-07-31
|
1997-04-09
|
0.25
|
1997-04-30
|
1996-12-26
|
0.24
|
1997-02-01
|
1996-10-09
|
0.24
|
1996-10-31
|
1996-07-10
|
0.24
|
1996-07-31
|
1996-04-10
|
0.24
|
1996-04-30
|
1996-01-10
|
0.22
|
1996-01-31
|
1995-10-11
|
0.22
|
1995-10-31
|
1995-07-12
|
0.22
|
1995-07-31
|
1995-04-07
|
0.22
|
1995-04-28
|
1995-01-09
|
0.19
|
1995-01-31
|
1994-10-07
|
0.19
|
1994-10-31
|
1994-07-11
|
0.19
|
1994-07-29
|
1994-04-11
|
0.19
|
1994-04-29
|
1994-01-10
|
0.17
|
1994-01-31
|
1993-10-08
|
0.17
|
1993-10-29
|
1993-07-19
|
0.17
|
1993-07-30
|
1993-04-12
|
0.35
|
1993-04-30
|
1993-01-11
|
0.33
|
1993-01-29
|
1992-10-09
|
0.33
|
1992-10-30
|
1992-07-13
|
0.33
|
1992-07-31
|
1992-04-10
|
0.33
|
1992-04-30
|
1992-01-06
|
0.32
|
1992-01-31
|
1991-10-07
|
0.32
|
1991-10-31
|
1991-07-15
|
0.31
|
1991-07-31
|
1991-04-08
|
0.31
|
1991-04-30
|
1991-01-07
|
0.31
|
1991-01-31
|
1990-10-05
|
0.31
|
1990-10-31
|
1990-07-09
|
0.31
|
1990-07-31
|
1990-04-06
|
0.31
|
1990-04-30
|
1990-01-08
|
0.31
|
1990-01-31
|
1989-10-06
|
0.31
|
1989-10-31
|
1989-07-10
|
0.30
|
1989-07-31
|
1989-04-10
|
0.30
|
1989-04-28
|
1989-01-09
|
0.29
|
1989-01-31
|
1988-10-07
|
0.29
|
1988-10-31
|
1988-07-11
|
0.27
|
1988-07-29
|
1988-04-04
|
0.27
|
1988-04-29
|
1988-01-11
|
0.26
|
1988-01-29
|
1987-10-09
|
0.26
|
1987-10-30
|
1987-07-06
|
0.25
|
1987-07-31
|
1987-04-06
|
0.25
|
1987-04-30
|
1987-01-05
|
0.24
|
1987-01-30
|
1986-12-24
|
0.24
|
1987-01-30
|
1986-10-06
|
0.24
|
1986-10-31
|
1986-07-07
|
0.24
|
1986-07-31
|
1986-04-07
|
0.24
|
1986-04-30
|
1986-01-06
|
0.24
|
1986-01-31
|
1985-10-07
|
0.24
|
1985-10-31
|
1985-07-08
|
0.23
|
1985-07-31
|
1985-04-08
|
0.23
|
1985-04-30
|
